Galena Biopharma Acquires Mills Pharmaceuticals, LLC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Roth Capital Raises PT on Galena Biopharma (GALE) Following Mills Pharmaceuticals Purchase
January 13, 2014 9:31 AM ESTRoth Capital maintains its Buy rating on Galena Biopharma (Nasdaq: GALE), but raises its price target from $7 up to $11 following the... More
